Blue Water Acquisition Corp. III Class A Ordinary Shares

GREENWICH, Conn., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (Nasdaq: BLUW), a special purpose acquisition company (“Blue Water”), today announced that its stockholders have voted to approve the proposed business combination (the “Business Combination”) with Clarus Therapeutics, Inc., a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women (“Clarus”) at its special meeting of stockholders (the “Special Meeting”) held today, August 27, 2021.

Related tickers: BLUWU, BLUWW, BLUW.

NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Blue Water Acquisition Corp. (NASDAQ: BLUW) (“Blue Water” or the "Company"), a special purpose acquisition company (SPAC) that previously announced a planned business combination with Clarus Therapeutics, Inc. ("Clarus"), announced today that the special meeting of its stockholders (the “Special Meeting”) originally scheduled for Thursday, August 12, 2021, is being postponed to Friday, August 27, 2021.

Related tickers: BLUWU, BLUWW, BLUW.